Clinical Trial Update: Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg [NA]

View source ↗

Summary

This clinical trial update evaluates the clinical effect and safety of increasing tamsulosin from 0.2 mg to 0.4 mg in patients with LUTS/BPH who were refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Benign Prostatic Hyperplasia | NA | Status: UNKNOWN